Winnovation Culturaltainment Development (000620.SZ) plans to launch a 2026 restricted stock incentive plan.
Winnovation Culturaltainment Development (000620.SZ) disclosed a draft 2026 restricted stock incentive plan, proposing to grant no more than 50 million restricted shares to incentive recipients, accounting for approximately 0.85% of the company's total share capital at the time of the announcement of the draft incentive plan. Of these, no more than 44 million shares will be granted for the first time, and no more than 6 million shares will be reserved. The grant price of the restricted shares (including the reserved portion) is 1.58 yuan per share. The total number of incentive recipients for the first grant is 84.
Winnovation Culturaltainment Development (000620.SZ) disclosed the draft of its 2026 restricted stock incentive plan, proposing to grant no more than 50 million restricted shares to incentive recipients, accounting for approximately 0.85% of the company's total share capital at the time of the announcement of the draft incentive plan. Of these, no more than 44 million shares will be granted for the first time, and no more than 6 million shares will be reserved. The grant price of the restricted shares (including the reserved portion) is 1.58 yuan per share. The total number of incentive recipients for the first grant is 84.
Related Articles

Tongding Interconnection Information (002491.SZ) plans to acquire partial equity of Nanjing Heben Electromechanical for 100 million yuan.

Zhuzhou Tianqiao Crane (002523.SZ) plans to launch a 2026 restricted stock incentive plan.

Haisco Pharmaceutical Group (002653.SZ): Innovative Drug HSK42360-Na Tablets Included in Breakthrough Therapy Designation Program
Tongding Interconnection Information (002491.SZ) plans to acquire partial equity of Nanjing Heben Electromechanical for 100 million yuan.

Zhuzhou Tianqiao Crane (002523.SZ) plans to launch a 2026 restricted stock incentive plan.

Haisco Pharmaceutical Group (002653.SZ): Innovative Drug HSK42360-Na Tablets Included in Breakthrough Therapy Designation Program






